Literature DB >> 25106487

The diagnostic value of SE MRI and DWI of the spine in patients with monoclonal gammopathy of undetermined significance, smouldering myeloma and multiple myeloma.

Julie C Dutoit1, Matthias A Vanderkerken, Joris Anthonissen, Frederick Dochy, Koenraad L Verstraete.   

Abstract

OBJECTIVES: To evaluate DWI of the bone marrow in the differentiation of monoclonal gammopathy of undetermined significance (MGUS), smouldering myeloma (SMM) and multiple myeloma (MM).
METHODS: The retrospective study includes 64 patients with MGUS, 27 with SMM, 64 with new MM and 12 controls. Signal intensity (SI) of spinal SE-MRI and DWI (b0-1000) as well as apparent diffusion coefficients (ADC) were measured in the T10 and L3. Qualitative assessment of b-images was performed by one experienced radiologist.
RESULTS: ADC600 and ADC1000 are the best ADC values in differentiating patient groups (p < 0.030). SIT2, SIb1000 and ADC1000 are higher and SIT1 lower in L3 compared to T10 (p < 0.050). All quantitative parameters of L3 can differentiate significantly between MGUS and MM (p < 0.050) and between patients with percentage plasma cells (PC%) between 0-10 % compared to >50 % (p = 0.001). Only SIT2 for L3 can differentiate MGUS from SMM (p = 0.044) and PC%0-10 from PC%10-25 (p = 0.033). Qualitative interpretation of b1000 images allows differentiating MM patients from those with MGUS or SMM (p < 0.001).
CONCLUSIONS: Spinal SE-MRI can differentiate among MGUS, SMM, MM and control subjects. DWI based on the SI on b1000 images and ADC values is increased in MM compared to MGUS and SMM. Qualitative assessment of b-images can differentiate MM from MGUS or SMM. KEY POINTS: • ADC values are higher in patients with MM compared to MGUS • DWI parameters change late in disease evolution • DWI is sensitive but not specific in diagnosing patients with MM • Qualitative DWI assessment is good in detecting myeloma patients.

Entities:  

Mesh:

Year:  2014        PMID: 25106487     DOI: 10.1007/s00330-014-3324-5

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  27 in total

1.  Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and diffusion-weighted imaging of bone marrow in healthy individuals.

Authors:  Jens Hillengass; Bram Stieltjes; Tobias Bäuerle; Fabienne McClanahan; Christiane Heiss; Thomas Hielscher; Barbara Wagner-Gund; Verena Habetler; Hartmut Goldschmidt; Heinz-Peter Schlemmer; Stefan Delorme; Christian M Zechmann
Journal:  Acta Radiol       Date:  2011-03-03       Impact factor: 1.990

Review 2.  Multiple myeloma precursor disease: current clinical and epidemiological insights and future opportunities.

Authors:  Ola Landgren; Neha Korde
Journal:  Oncology (Williston Park)       Date:  2011-06       Impact factor: 2.990

3.  Early response assessment in patients with multiple myeloma during anti-angiogenic therapy using arterial spin labelling: first clinical results.

Authors:  Michael Fenchel; Marina Konaktchieva; Katja Weisel; Sabina Kraus; Harald Brodoefel; Claus D Claussen; Marius Horger
Journal:  Eur Radiol       Date:  2010-07-01       Impact factor: 5.315

4.  Age-related distribution of vertebral bone-marrow diffusivity.

Authors:  Jochen Herrmann; Nina Krstin; Bjoern P Schoennagel; Marjike Sornsakrin; Thorsten Derlin; Jasmin D Busch; Kay Uwe Petersen; Joachim Graessner; Gerhard Adam; Christian R Habermann
Journal:  Eur J Radiol       Date:  2012-09-25       Impact factor: 3.528

5.  Assessing the relation between bone marrow signal intensity and apparent diffusion coefficient in diffusion-weighted MRI.

Authors:  Anwar R Padhani; Katherine van Ree; David J Collins; Shirley D'Sa; Andreas Makris
Journal:  AJR Am J Roentgenol       Date:  2013-01       Impact factor: 3.959

6.  Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group.

Authors: 
Journal:  Br J Haematol       Date:  2003-06       Impact factor: 6.998

Review 7.  Diffusion-weighted imaging of bone marrow.

Authors:  Olaf Dietrich; Andreas Biffar; Maximilian F Reiser; Andrea Baur-Melnyk
Journal:  Semin Musculoskelet Radiol       Date:  2009-05-19       Impact factor: 1.777

8.  Value of whole body MRI and dynamic contrast enhanced MRI in the diagnosis, follow-up and evaluation of disease activity and extent in multiple myeloma.

Authors:  Julie C Dutoit; Matthias A Vanderkerken; Koenraad L Verstraete
Journal:  Eur J Radiol       Date:  2013-05-28       Impact factor: 3.528

9.  Assessing response of myeloma bone disease with diffusion-weighted MRI.

Authors:  C Messiou; S Giles; D J Collins; S West; F E Davies; G J Morgan; N M Desouza
Journal:  Br J Radiol       Date:  2012-12       Impact factor: 3.039

10.  Do apparent diffusion coefficient (ADC) values obtained using high b-values with a 3-T MRI correlate better than a transrectal ultrasound (TRUS)-guided biopsy with true Gleason scores obtained from radical prostatectomy specimens for patients with prostate cancer?

Authors:  Kazuhiro Kitajima; Satoru Takahashi; Yoshiko Ueno; Hideaki Miyake; Masato Fujisawa; Fumi Kawakami; Kazuro Sugimura
Journal:  Eur J Radiol       Date:  2013-03-19       Impact factor: 3.528

View more
  16 in total

1.  The use of whole-body MRI in multiple myeloma.

Authors:  Mark Portet; Emma Owens; David Howlett
Journal:  Clin Med (Lond)       Date:  2019-07       Impact factor: 2.659

Review 2.  Prognostic significance of focal lesions and diffuse infiltration on MRI for multiple myeloma: a meta-analysis.

Authors:  So-Yeon Lee; Hyun-Jung Kim; Yu Ri Shin; Hee-Jin Park; Yun-Gyoo Lee; Suk Joong Oh
Journal:  Eur Radiol       Date:  2016-09-05       Impact factor: 5.315

Review 3.  Whole-body MRI, dynamic contrast-enhanced MRI, and diffusion-weighted imaging for the staging of multiple myeloma.

Authors:  Julie C Dutoit; Koenraad L Verstraete
Journal:  Skeletal Radiol       Date:  2017-03-13       Impact factor: 2.199

4.  Inter-observer agreement for the evaluation of bone involvement on Whole Body Low Dose Computed Tomography (WBLDCT) in Multiple Myeloma (MM).

Authors:  M Zacchino; P A Bonaffini; A Corso; V Minetti; A Nasatti; C Tinelli; R Dore; F Calliada; S Sironi
Journal:  Eur Radiol       Date:  2015-05-20       Impact factor: 5.315

5.  Diffusion-weighted imaging (DWI) in diagnosis, staging, and treatment response assessment of multiple myeloma: a systematic review and meta-analysis.

Authors:  Pooya Torkian; Bahar Mansoori; Jens Hillengass; Javid Azadbakht; Sina Rashedi; Sarah S Lee; Behrang Amini; Pietro Andrea Bonaffini; Majid Chalian
Journal:  Skeletal Radiol       Date:  2022-07-26       Impact factor: 2.128

6.  Prognostic significance of increased bone marrow microcirculation in newly diagnosed multiple myeloma: results of a prospective DCE-MRI study.

Authors:  Maximilian Merz; Thomas M Moehler; Judith Ritsch; Tobias Bäuerle; Christian M Zechmann; Barbara Wagner; Anna Jauch; Dirk Hose; Christina Kunz; Thomas Hielscher; Hendrik Laue; Hartmut Goldschmidt; Stefan Delorme; Jens Hillengass
Journal:  Eur Radiol       Date:  2015-07-29       Impact factor: 5.315

7.  Association between magnetic resonance imaging patterns and baseline disease features in multiple myeloma: analyzing surrogates of tumour mass and biology.

Authors:  Elias K Mai; Thomas Hielscher; Jost K Kloth; Maximilian Merz; Sofia Shah; Michaela Hillengass; Barbara Wagner; Dirk Hose; M S Raab; Anna Jauch; Stefan Delorme; Hartmut Goldschmidt; Marc-André Weber; Jens Hillengass
Journal:  Eur Radiol       Date:  2016-01-15       Impact factor: 5.315

Review 8.  Applications of PET-MRI in musculoskeletal disease.

Authors:  Feliks Kogan; Stephen M Broski; Daehyun Yoon; Garry E Gold
Journal:  J Magn Reson Imaging       Date:  2018-07       Impact factor: 4.813

9.  Evaluation of bone marrow infiltration in multiple myeloma using whole-body diffusion-weighted imaging and T1-weighted water-fat separation Dixon.

Authors:  Xiaodong Ji; Wenyang Huang; Huazheng Dong; Zhiwei Shen; Meizhu Zheng; Dehui Zou; Wen Shen; Shuang Xia
Journal:  Quant Imaging Med Surg       Date:  2021-02

Review 10.  MRI in multiple myeloma: a pictorial review of diagnostic and post-treatment findings.

Authors:  Julie C Dutoit; Koenraad L Verstraete
Journal:  Insights Imaging       Date:  2016-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.